Kenneth S Boger - Net Worth and Insider Trading
Kenneth S Boger Net Worth
The estimated net worth of Kenneth S Boger is at least $136 Million dollars as of 2024-09-21. Kenneth S Boger is the SVP & Chief Legal Officer of Vertex Pharmaceuticals Inc and owns about 292,187 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $136 Million. Details can be seen in Kenneth S Boger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth S Boger has not made any transactions after 2011-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kenneth S Boger
Kenneth S Boger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth S Boger owns 1 companies in total, including Vertex Pharmaceuticals Inc (VRTX) .
Click here to see the complete history of Kenneth S Boger’s form 4 insider trades.
Insider Ownership Summary of Kenneth S Boger
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2011-09-13 | SVP & General Counsel |
Kenneth S Boger Latest Holdings Summary
Kenneth S Boger currently owns a total of 1 stock. Kenneth S Boger owns 292,187 shares of Vertex Pharmaceuticals Inc (VRTX) as of September 13, 2011, with a value of $136 Million.
Latest Holdings of Kenneth S Boger
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2011-09-13 | 292,187 | 464.92 | 135,843,580 |
Holding Weightings of Kenneth S Boger
Kenneth S Boger Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth S Boger has made a total of 0 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 22,000 shares on September 13, 2011, which brought Kenneth S Boger around $1 Million.
Insider Trading History of Kenneth S Boger
- 1
Kenneth S Boger Trading Performance
GuruFocus tracks the stock performance after each of Kenneth S Boger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kenneth S Boger is 21.82%. GuruFocus also compares Kenneth S Boger's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kenneth S Boger within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kenneth S Boger's insider trading performs compared to the benchmark.
Performance of Kenneth S Boger
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.39 | | | | | |
| Relative Return to S&P 500(%) | -0.76 | | | | | |
Kenneth S Boger Ownership Network
Kenneth S Boger Owned Company Details
What does Vertex Pharmaceuticals Inc do?
Who are the key executives at Vertex Pharmaceuticals Inc?
Kenneth S Boger is the SVP & General Counsel of Vertex Pharmaceuticals Inc. Other key executives at Vertex Pharmaceuticals Inc include EVP and CMO Carmen Bozic , director & CEO & President Reshma Kewalramani , and EVP & Chief Technical Ops. Off. Atkinson Edward Morrow Iii .
Vertex Pharmaceuticals Inc (VRTX) Insider Trades Summary
Over the past 18 months, Kenneth S Boger made no insider transaction in Vertex Pharmaceuticals Inc (VRTX). Other recent insider transactions involving Vertex Pharmaceuticals Inc (VRTX) include a net sale of 47,585 shares made by Carmen Bozic , a net sale of 80,549 shares made by Reshma Kewalramani , and a net sale of 62,114 shares made by Jeffrey M Leiden .
In summary, during the past 3 months, insiders sold 50,541 shares of Vertex Pharmaceuticals Inc (VRTX) in total and bought 0 shares, with a net sale of 50,541 shares. During the past 18 months, 394,733 shares of Vertex Pharmaceuticals Inc (VRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 394,733 shares.
Vertex Pharmaceuticals Inc (VRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vertex Pharmaceuticals Inc Insider Transactions
Kenneth S Boger Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth S Boger. You might contact Kenneth S Boger via mailing address: C/o Ecoscience Corp, 10 Alvin Court, East Brunswick Nj 08816.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
